☆ 4.7 Editorial Material

Stereotactic radiosurgery alone for brain metastases

LANCET ONCOLOGY (2015)

期刊

LANCET ONCOLOGY

卷 16, 期 3, 页码 249-250

出版社

ELSEVIER SCIENCE INC

DOI: 10.1016/S1470-2045(14)71106-4

关键词

-

类别

Oncology

向作者/读者索取更多资源

Protocol

Reagent

作者

我是这篇论文的作者

点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.7

评分不足

次要评分

新颖性

-

重要性

-

科学严谨性

-

评价这篇论文

推荐

Article Oncology

SAFESTEREO: phase II randomized trial to compare stereotactic radiosurgery with fractionated stereotactic radiosurgery for brain metastases

J. A. Crouzen, A. L. Petoukhova, M. L. D. Broekman, M. Fiocco, U. J. Fisscher, J. H. Franssen, C. G. M. Gadellaa-van Hooijdonk, M. Kerkhof, M. Kiderlen, M. E. Mast, C. M. van Rij, R. Nandoe Tewarie, M. A. E. van de Sande, P. P. G. van der Toorn, R. Vlasman, M. J. Vos, N. C. M. G. van der Voort van Zyp, R. G. J. Wiggenraad, L. M. Wiltink, J. D. Zindler

Summary: A multicenter prospective randomized study aims to compare the incidence of adverse local events in patients with brain metastases using fractionated stereotactic radiosurgery (fSRS) versus stereotactic radiosurgery (SRS) in one or three fractions. The study aims to reduce the risk of radionecrosis and improve the effectiveness of brain metastases treatment.

BMC CANCER (2023)

添加到收藏夹

Article Clinical Neurology

Stereotactic Radiosurgery for Intraventricular Metastases: A Multicenter Study

Georgios Mantziaris, Stylianos Pikis, Zhiyuan Xu, Reed Mullen, Juan Alzate, Kenneth Bernstein, Douglas Kondziolka, Zhishuo Wei, Ajay Niranjan, L. Dade Lunsford, Roman Liscak, Jaromir May, Cheng-chia Lee, Huai-che Yang, Francois-Louis Coupe, David Mathieu, Kimball Sheehan, Darrah Sheehan, Joshua D. Palmer, Haley K. Perlow, Selcuk Peker, Yavuz Samanci, Jennifer Peterson, Daniel M. Trifiletti, Matthew J. Shepard, Shahed Elhamdani, Rodney E. Wegner, Herwin Speckter, Wenceslao Hernandez, Ronald E. Warnick, Jason Sheehan

Summary: This retrospective study showed that stereotactic radiosurgery (SRS) is an effective treatment option for intraventricular metastases (IVMs), with a comparable local control rate to SRS for parenchymal brain metastases. However, careful follow-up is needed to detect leptomeningeal spread and hydrocephalus in patients with IVMs.

NEUROSURGERY (2023)

添加到收藏夹

Review Oncology

Integration of Systemic Therapy and Stereotactic Radiosurgery for Brain Metastases

Raees Tonse, Martin C. Tom, Minesh P. Mehta, Manmeet S. Ahluwalia, Rupesh Kotecha

Summary: In modern times, brain metastasis requires multi-modal management and interdisciplinary care. Traditionally, treatment strategies have focused on local treatments alone due to limited efficacy of cytotoxic chemotherapy. However, with the availability of molecular-based therapies with central nervous system penetration, individualized selection of tailored systemic therapies can now be used alongside local treatments. Moreover, the introduction of immune checkpoint inhibitors has further revolutionized the management of brain metastasis patients.

CANCERS (2021)

添加到收藏夹

Article Clinical Neurology

Quality-of-life trajectories after stereotactic radiosurgery for brain metastases

Adomas Bunevicius, Karen Lavezzo, Leah Shabo, Jesse McClure, Jason P. Sheehan

Summary: The study evaluated the quality of life in patients treated with stereotactic radiosurgery for brain metastases, finding that the quality of life remained largely stable post-treatment. Factors such as the patient's RPA class, upfront whole-brain radiation therapy, and the number of intracranial lesions were identified as independent predictors of post-treatment quality of life deterioration. Additionally, a lower pre-treatment quality of life was associated with shorter survival independently of other clinical and demographic variables.

JOURNAL OF NEUROSURGERY (2021)

添加到收藏夹

Article Clinical Neurology

Stereotactic radiosurgery for prostate cancer cerebral metastases: an international multicenter study

Stylianos Pikis, Adomas Bunevicius, Cheng-Chia Lee, Huai-Che Yang, Brad E. Zacharia, Roman Liscak, Gabriela Simonova, Manjul Tripathi, Narendra Kumar, David Mathieu, Remi Perron, Selcuk Peker, Yavuz Samanci, Jason Gurewitz, Kenneth Bernstein, Douglas Kondziolka, Ajay Niranjan, L. Dade Lunsford, Nikolaos Mantziaris, Jason P. Sheehan

Summary: This multicenter study evaluated the safety and efficacy of stereotactic radiosurgery (SRS) in the management of intracranial prostate cancer metastases. The results showed that SRS was a safe, well-tolerated, and effective treatment option for these patients.

JOURNAL OF NEUROSURGERY (2022)

添加到收藏夹

Article Oncology

Stereotactic Radiation Therapy for Brain Metastases: Factors Affecting Outcomes and Radiation Necrosis

Angela Barillaro, Mara Caroprese, Laura Cella, Anna Viggiano, Francesca Buccelli, Chiara Daponte, Chiara Feoli, Caterina Oliviero, Stefania Clemente, Antonio Farella, Manuel Conson, Roberto Pacelli

Summary: Brain metastases are severe events in patients with solid tumors. Stereotactic radiation therapy is an effective treatment for brain metastases, but it may lead to radiation necrosis, which can impact patient's quality of life. Prompt recognition and treatment are necessary for managing radiation necrosis.

CANCERS (2023)

添加到收藏夹

Article Radiology, Nuclear Medicine & Medical Imaging

Spatiotemporal fractionation schemes for stereotactic radiosurgery of multiple brain metastases

Nathan Torelli, David Papp, Jan Unkelbach

Summary: This study investigates the potential of spatiotemporal fractionation schemes to reduce the healthy brain's received biological dose in the treatment of brain metastases (BMs). The spatiotemporal fractionation schemes involve partial hypofractionation in the metastases and more uniform fractionation in the healthy brain. A constrained approach to spatiotemporal fractionation (cSTF) is proposed for patients with multiple brain metastases, which is more robust against uncertainties. The results show that spatiotemporal fractionation schemes can effectively reduce the healthy brain's biological dose.

MEDICAL PHYSICS (2023)

添加到收藏夹

Article Clinical Neurology

Neoadjuvant stereotactic radiosurgery for brain metastases: a new paradigm

Yuping Derek Li, Andrew T. Coxon, Jiayi Huang, Christopher D. Abraham, Joshua L. Dowling, Eric C. Leuthardt, Gavin P. Dunn, Albert H. Kim, Ralph G. Dacey, Gregory J. Zipfel, John Evans, Eric A. Filiput, Michael R. Chicoine

Summary: Neoadjuvant SRS, as a new treatment paradigm, shows the potential for improved outcomes compared with postoperative SRS, mitigating the limitations of the latter.

NEUROSURGICAL FOCUS (2022)

添加到收藏夹

Review Oncology

Optimizing the synergy between stereotactic radiosurgery and immunotherapy for brain metastases

Kelly H. Yoo, David J. Park, John H. Choi, Neelan J. Marianayagam, Michael Lim, Antonio Meola, Steven D. Chang

Summary: Solid tumors metastasizing to the brain are a common occurrence, and conventional treatments like surgical resection and whole-brain radiotherapy have limitations in long-term survival and local control outcomes. Stereotactic radiosurgery (SRS) has emerged as an alternative approach to improve control rates, and the use of high-dose radiation has sparked interest in eliciting antitumor immunity. The blood-brain barrier has traditionally posed a challenge to systemic therapy, but recent developments in immunotherapy show promise in managing intracranial metastasis.

FRONTIERS IN ONCOLOGY (2023)

添加到收藏夹

Article Clinical Neurology

Adverse radiation effect and freedom from progression following repeat stereotactic radiosurgery for brain metastases

Penny K. Sneed, Jason W. Chan, Lijun Ma, Steve E. Braunstein, Philip Theodosopoulos, Shannon E. Fogh, Jean L. Nakamura, Lauren Boreta, David R. Raleigh, Benjamin P. Ziemer, Olivier Morin, Shawn L. Hervey-Jumper, Michael W. McDermott

Summary: This study evaluates the risk and time course of adverse radiation effects (AREs) in patients with brain metastases previously treated with stereotactic radiosurgery (SRS) and salvage SRS. The authors found that repeat single-fraction SRS had good outcomes for brain metastases <= 2 cm, with a low risk of symptomatic AREs.

JOURNAL OF NEUROSURGERY (2023)

添加到收藏夹

Article Biochemistry & Molecular Biology

Presence of Activated (Phosphorylated) STAT3 in Radiation Necrosis Following Stereotactic Radiosurgery for Brain Metastases

Paola Anna Jablonska, Nuria Galan, Jennifer Barranco, Sergio Leon, Ramon Robledano, Jose Ignacio Echeveste, Alfonso Calvo, Javier Aristu, Diego Serrano

Summary: This study investigates the role of STAT3 and other inflammatory markers in the development of brain radiation necrosis (RN). The results suggest that STAT3 plays an important role in RN development, and targeting STAT3 may be a promising strategy for ameliorating symptomatic RN in brain metastases patients undergoing stereotactic radiosurgery (SRS).

INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2023)

添加到收藏夹

Article Oncology

Repeated Stereotactic Radiotherapy for Local Brain Metastases Failure or Distant Brain Recurrent: A Retrospective Study of 184 Patients

Laure Kuntz, Clara Le Fevre, Delphine Jarnet, Audrey Keller, Philippe Meyer, Christophe Mazzara, Helene Cebula, Georges Noel, Delphine Antoni

Summary: This retrospective study analyzed the data of patients who received at least two courses of SRT between 2010 and 2020. The results showed that NDFS and OS after SRT were influenced by various factors, including the number of treatments, patient condition, salvage WBRT, and metastasis velocity.

CANCERS (2023)

添加到收藏夹

Article Endocrinology & Metabolism

Stereotactic Radiosurgery for Differentiated Thyroid Cancer Brain Metastases: An International, Multicenter Study

Adomas Bunevicius, Sarah Fribance, Stylianos Pikis, John Y. K. Lee, Love Y. Buch, Michael Moran, Andrew I. Yang, Kenneth Bernstein, David Mathieu, Remi Perron, Roman Liscak, Gabriela Simonova, Samir Patel, Daniel M. Trifiletti, Roberto Martinez Alvarez, Nuria Martinez Moreno, Cheng-chia Lee, Huai-che Yang, Ben A. Strickland, Gabriel Zada, Eric L. Chang, Douglas Kondziolka, Jason Sheehan

Summary: This study evaluated the efficacy and safety of stereotactic radiosurgery (SRS) for differentiated thyroid cancer brain metastases (BM). SRS provided durable local control for the majority of patients with papillary and follicular thyroid cancer BMs, with a low risk of adverse radiation events. However, patients with multiple BMs or poor functional status prior to SRS had shorter overall survival.

THYROID (2021)

添加到收藏夹

Review Oncology

Dose-Response Effect and Dose-Toxicity in Stereotactic Radiotherapy for Brain Metastases: A Review

Maxime Loo, Jean-Baptiste Clavier, Justine Attal Khalifa, Elisabeth Moyal, Jonathan Khalifa

Summary: Brain metastases are a common complication for cancer patients, with stereotactic radiosurgery considered a cornerstone treatment. The ideal dose and fractionation schedule remain unknown, with ongoing debates regarding the use of hypofractionated schedules and the linear-quadratic model. Recent studies have shown the importance of radiation schedule in immunomodulatory responses. Efficacy and toxicity data suggest that hypofractionated schedules may offer benefits in terms of reducing toxicity and improving local control rates compared to single-fraction treatment.

CANCERS (2021)

添加到收藏夹

Article Oncology

Cyberknife(R) hypofractionated stereotactic radiosurgery (CK-hSRS) as salvage treatment for brain metastases

Sergej Telentschak, Daniel Ruess, Stefan Grau, Roland Goldbrunner, Niklas von Spreckelsen, Karolina Jablonska, Harald Treuer, Martin Kocher, Maximilian Ruge

Summary: The study retrospectively analyzed 34 patients treated with CK-hSRS, showing good treatment effectiveness with high local control rates but a 12% complication rate.

JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY (2021)

添加到收藏夹

Letter Clinical Neurology

How safe, really, is jugular paraganglioma radiosurgery?

Jonathan P. S. Knisely, Rohan Ramakrishna, Theodore H. Schwartz

JOURNAL OF NEUROSURGERY (2019)

添加到收藏夹

Editorial Material Oncology

The ASTRO Research Portfolio: Where Do We Go From Here?

James B. Yu, Tyler F. Beck, Mitchell S. Anscher, Andrew M. Baschnagel, Kristy K. Brock, David J. Carlson, Michael M. Dominello, Randall J. Kimple, Jonathan P. S. Knisely, Marc S. Mendonca, Omar Y. Mian, Anurag K. Singh, Eduardo G. Moros, Judith C. Keen

INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS (2019)

添加到收藏夹

Article Oncology

Analysis of the 2017 American Society for Radiation Oncology (ASTRO) Research Portfolio

James B. Yu, Tyler F. Beck, Mitchell S. Anscher, Andrew M. Baschnagel, Kristy K. Brock, David J. Carlson, Michael M. Dominello, Randall J. Kimple, Jonathan P. Knisely, Marc S. Mendonca, Omar Y. Mian, Anurag K. Singh, Eduardo G. Moros, Judith C. Keen

INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS (2019)

添加到收藏夹

Article Clinical Neurology

Gallium-68 DOTATATE PET in the Evaluation of Intracranial Meningiomas

Jana Ivanidze, Michelle Roytman, Eaton Lin, Rajiv S. Magge, David J. Pisapia, Benjamin Liechty, Nicolas Karakatsanis, Rohan Ramakrishna, Jonathan Knisely, Theodore H. Schwartz, Joseph R. Osborne, Susan C. Pannullo

JOURNAL OF NEUROIMAGING (2019)

添加到收藏夹

Meeting Abstract Oncology

A Dosimetric Evaluation of 6 MV Versus 10 MV Photon Whole-Brain Radiation Therapy

S. S. Mahase, D. A. Julie, K. Salah, P. Christos, J. P. S. Knisely

INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS (2019)

添加到收藏夹

Article Clinical Neurology

A Multidisciplinary Team Approach to Brain and Spine Stereotactic Radiosurgery Conferences: A Unique Institutional Model

Swathi Chidambaram, Graham M. Winston, Jonathan P. S. Knisely, Rohan Ramakrishna, Rupa Juthani, Khaled Salah, John T. McKenna, Gabor Jozsef, Danielle Cardona, Susan C. Pannullo

WORLD NEUROSURGERY (2019)

添加到收藏夹

Article Clinical Neurology

Worldwide Access to Stereotactic Radiosurgery

Susan C. Pannullo, Diana A. R. Julie, Swathi Chidambaram, Onyinye D. Balogun, Silvia Chiara Formenti, Michael L. J. Apuzzo, Jonathan P. S. Knisely

WORLD NEUROSURGERY (2019)

添加到收藏夹

Article Clinical Neurology

Historical Aspects of Stereotactic Radiosurgery: Concepts, People, and Devices

Jonathan P. S. Knisely, Michael L. J. Apuzzo

WORLD NEUROSURGERY (2019)

添加到收藏夹

Article Oncology

Possible Abscopal Effect Observed in Frontal Meningioma After Localized IMRT on Posterior Meningioma Resection Cavity Without Adjuvant Immunotherapy

Danielle Golub, Kevin Kwan, Jonathan P. S. Knisely, Michael Schulder

FRONTIERS IN ONCOLOGY (2019)

添加到收藏夹

Editorial Material Oncology

What Would I Want Done for My Mother?

Jonathan P. S. Knisely

INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS (2019)

添加到收藏夹

Article Oncology

Reirradiation for Recurrent Glioblastoma: What We Know and What We Do Not

Jonathan P. S. Knisely, Howard A. Fine

Summary: The Oncology Grand Rounds series aims to provide clinical context to original reports published in the Journal. It includes case presentations, discussions on diagnostic and management challenges, literature reviews, and suggested management approaches by the authors. The goal is to help readers apply key study findings, including those from the Journal of Clinical Oncology, to their own clinical practice.

JOURNAL OF CLINICAL ONCOLOGY (2023)

添加到收藏夹

Letter Oncology

Glioma patient-reported outcome assessment in clinical care

Constantin Tuleasca, Jonathan Knisely, Henri-Arthur Leroy, Andreas F. Hottinger, Iulia Peciu-Florianu, Marc Levivier, Nicolas Reyns

LANCET ONCOLOGY (2020)

添加到收藏夹

Article Medicine, General & Internal

Clinical Considerations in Neurosurgical Radiosurgery in the Time of COVID-19

Susan C. Pannullo, Swathi Chidambaram, Andrew Brandmaier, Jonathan Knisely, John Adler

CUREUS JOURNAL OF MEDICAL SCIENCE (2020)

添加到收藏夹

Meeting Abstract Oncology

EFFECT OF RIND-BASED DOSIMETRIC TECHNIQUES FOR SCALP DOSE REDUCTION IN BRAIN IRRADIATION

Diana No, Diana Julie, Jonathan Knisely

NEURO-ONCOLOGY (2019)

添加到收藏夹

Meeting Abstract Oncology

ATYPICAL MENINGIOMA: EARLY OUTCOMES WITH OR WITHOUT POSTOPERATIVE RADIATION

Peter Pan, David Pisapia, Rohan Ramakrishna, Theodore Schwartz, Philip Stieg, Howard Fine, Susan Pannullo, Jonathan Knisely, Gloria Chiang, Jana Ivanidze, Benjamin Liechty, Andrew Brandmaier, Rajiv Magge

NEURO-ONCOLOGY (2019)

添加到收藏夹

暂无数据

© Peeref 2019-2024. All rights reserved.